Francis Ayuk

Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Anne M. Spanjaart, Per Ljungman, Rafael de la Cámara et al. · Leukemia · 2021 · 116 citations · Full text

Medicine, Hematology, Infectious Diseases +16

Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase

Florian Länger, Brigitte Spath, Cornelia Fischer et al. · Blood · 2013 · 110 citations · Full text

Life Sciences, Immunology, Molecular Biology +13

Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma

Georgia Schilling, Timon Hansen, Avichai Shimoni et al. · Leukemia · 2008 · 83 citations

Medicine, Genetics, Hematology +16

Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis

Haefaa Alchalby, Dr. Md. Yunus, Tatjana Zabelina et al. · Bone Marrow Transplantation · 2016 · 74 citations

Medicine, Hematology, Immunology +16

Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy: a GLA/DRST study

Nico Gagelmann, Gerald Wulf, Johannes Duell et al. · Blood Advances · 2022 · 55 citations · Full text

Life Sciences, Hematology, Immunology +17